Sirion Therapeutics
Sirion Therapeutics is a biopharmaceutical company, engaged in developing, and commercializing of products for the protection of eyesight.
Funding reportedLast round: Series B
What company datasets say Sirion Therapeutics raised
Funding, as reported
Reported in all45Min the source's currency
Rounds2
Last roundSeries B
Last round dateApr 2007
Investors listed5
Biopharma in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Sirion Therapeutics in front of investors. Or tell us what we have wrong.